Methods Patients were divided randomly into two groups. Group A(29 cases) was treated with MPA MVP regimen,Group B(27 cases) was treated with MVP regimen. The objective response and toxicity were assessed by WHO criteria.

• 方法 A组 (2 9例 )接受甲孕酮 +MVP方案治疗 ,B组 (2 7例 )接受 MVP方案治疗 ,采用单盲随机分组 ,毒性反应按 WHO标准进行评价。